Icecure Medical LtdNASDAQ:ICCM
- LAST PRICE1.2000
- TODAY'S CHANGE (%)0.0100 (0.8403%)
- Bid / Lots1.1400/ 5
- Ask / Lots1.2100/ 87
- Open / Previous Close1.2100 / 1.1900
- Day Range
- 52 Week Range
- Volume60,561
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ICCM |
|---|---|---|
| 09:32 ET | 1263 | 1.2 |
| 09:34 ET | 3212 | 1.2006 |
| 09:39 ET | 200 | 1.2 |
| 09:48 ET | 200 | 1.2182 |
| 10:12 ET | 100 | 1.2 |
| 10:15 ET | 100 | 1.2 |
| 10:32 ET | 400 | 1.2 |
| 10:44 ET | 500 | 1.1928 |
| 10:46 ET | 2910 | 1.18 |
| 10:50 ET | 600 | 1.19 |
| 11:11 ET | 857 | 1.182 |
| 11:18 ET | 5181 | 1.1898 |
| 11:20 ET | 5900 | 1.19 |
| 11:29 ET | 1000 | 1.1972 |
| 12:00 ET | 300 | 1.1989 |
| 12:02 ET | 100 | 1.19 |
| 12:09 ET | 2505 | 1.1906 |
| 12:12 ET | 2505 | 1.1906 |
| 12:18 ET | 477 | 1.19 |
| 12:23 ET | 200 | 1.1901 |
| 12:45 ET | 218 | 1.19 |
| 12:50 ET | 100 | 1.2 |
| 12:56 ET | 616 | 1.1925 |
| 01:06 ET | 1300 | 1.195 |
| 01:10 ET | 100 | 1.195 |
| 01:12 ET | 100 | 1.1987 |
| 01:21 ET | 2000 | 1.1908 |
| 01:50 ET | 100 | 1.1999 |
| 02:45 ET | 500 | 1.191 |
| 03:02 ET | 1000 | 1.1908 |
| 03:05 ET | 1284 | 1.2 |
| 03:16 ET | 10281 | 1.195 |
| 03:39 ET | 100 | 1.1999 |
| 03:45 ET | 100 | 1.195 |
| 03:48 ET | 2150 | 1.19 |
| 03:59 ET | 566 | 1.2 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Icecure Medical Ltd | 54.9M | -3.7x | --- |
Renalytix PLC | 39.1M | -0.7x | --- |
Know Labs Inc | 53.4M | -1.7x | --- |
Heartbeam Inc | 52.7M | -2.1x | --- |
Vivos Inc | 58.2M | -19.0x | --- |
Vicarious Surgical Inc | 47.5M | -0.5x | --- |
Company Information
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.
Contact Information
- Headquarters
- 7 Ha'eshel St., PO Box 3163CAESAREA, Israel 3079504
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Ron Mayron
- Chief Executive Officer, Director
- Eyal Shamir
- Vice President - Finance, Vice President - Operations
- Ronen Tsimerman
- Vice President-Clinics, Regulations and Quality Assurance
- Elisabeth Sadka
- Vice President - Research & Development
- Naum Muchnik
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $54.9M |
|---|---|
Revenue (TTM) | $3.2M |
Shares Outstanding | 45.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.86 |
EPS | $-0.32 |
Book Value | $0.27 |
P/E Ratio | -3.7x |
Price/Sales (TTM) | 17.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -482.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
